insights_auto
Why is DBV down 7.22%?
Dive Deeperchevron_right
DBV:EPA
DBV Technologies SA
€1.97
arrow_downward
-7.22%(-0.15) 1D
Nov 13, 5:36:23 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DBV...
Open
€2.10
High
€2.11
Low
€1.90
Mkt. cap
620.42M
Avg. vol.
1.23M
Volume
1.26M
52-wk high
€4.50
52-wk low
€1.53
EPS
-€0.65
Shares outstanding
314.39M
No. of employees
179
Open
€2.10
High
€2.11
Low
€1.90
Mkt. cap
620.42M
Avg. vol.
1.23M
Volume
1.26M
52-wk high
€4.50
52-wk low
€1.53
EPS
-€0.65
Shares outstanding
314.39M
No. of employees
179
News stories
From web sources and news partners
Idéal Investisseur
·
5 hours ago
DBV Technologies shares, among the biggest decliners in the SBF 120, fall 2.5%
Profile
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
About DBV Technologies SA
CEO-
Employees179
FoundedMar 29, 2002
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitedbv-technologies.com